Product Images Levetiracetam

This is a comparison of the effectiveness of placebo and two different doses of Levetiracetam (1000 mg/day and 3000 mg/day) on patients. The study includes 95 patients in the placebo group, 97 patients in the 1000 mg/day dose group, and 101 patients in the 3000 mg/day dose group. The results indicate that 9% of patients in the study experienced a certain outcome.*

This is a table showing the percentage of patients for a placebo group and a group taking Levetiracetam 2000 mg/day. The placebo group had 63% of patients, while the Levetiracetam group had 35.2% of patients.*

This is a statistical data related to two groups - Placebo and Levetiracetam. The numbers listed represent percentages or counts, possibly related to a study or experiment. The text includes various percentages and group sizes, but without additional context, it is not possible to determine the specific purpose or results of this data.*

This is a label containing information about Levetiracetam tablets, a generic version of Keppra. Each film-coated tablet contains 500mg of levetiracetam. The medication is manufactured by Zhejiang Jingxin Pharmaceutical Co., Ltd. It is advised to store the tablets at a temperature between 20°C to 25°C (68°F to 77°F). The tablets are scored and imprinted with "JX012 - L". A caution is provided, stating that federal law prohibits the transfer of this drug to anyone other than the patient for whom it was prescribed. The label also includes sections for quantity, lot number, expiration date, and product number.*